2 Minute Medicine Rewind March 16 – March 22, 2015
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Efficacy ...
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Efficacy ...
1. 33 out of 34 post-liver transplant hepatitis C virus (HCV) patients treated with the trial regimen (ombitasavir, ABT-450/r, dasabuvir, ...
1. A 12 to 24 week regimen of sofosbuvir and ribavirin induced a sustained viral response in hepatitis C (HCV) ...
Image: PD In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the ...
Image: PD 1. Patients with hepatitis C genotype 1 treated with a combination of faldaprevir, deleobuvir and ribavirin achieved sustained ...
Image: PD 1. The addition of sofosbuvir to peginterferon-ribavirin was effective at achieving sustained virologic response against HCV genotypes 1, ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.